Antibiotic Resistance in the Intensive Care Unit
| Autor: | F. Marco, Jordi Vila |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
biology
Pseudomonas aeruginosa business.industry Ceftazidime biochemical phenomena metabolism and nutrition bacterial infections and mycoses medicine.disease_cause biology.organism_classification Acinetobacter baumannii Microbiology Stenotrophomonas maltophilia Antibiotic resistance Staphylococcus aureus medicine business Enterobacter cloacae Antibacterial agent medicine.drug |
| Zdroj: | Infectious Diseases in Critical Care ISBN: 9783540344056 |
| Popis: | Nosocomial infections, especially those caused by antibacterial agent-resistant pathogens, represent an important source of morbidity and mortality for the patients in an ICU. Important antibacterial agent-resistant nosocomial pathogens include both Gram-negative (ESBL-producing Enterobacteriaceae and non-fermenting bacilli, such as Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia) and Gram-positive (methicillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant Enterococcus spp. [VRE]) bacteria. Overall, the prevalence of resistance is often highest in units where the most vulnerable patients are located and where antibacterial use is consequently the heaviest. For instance, ICU patients have shown twofold higher rates of MRSA, ceftazidime resistance among Enterobacter cloacae and P. aeruginosa, and vancomycin resistance among enterocci than in patients in general wards [1]. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|